论文部分内容阅读
目的探讨内镜黏膜切除术治疗早期食管癌和癌前病变的价值。方法本文选取了我院2011年1月至2012年4月间入院治疗的25例早期食管癌及癌前病变患者为研究对象,针对治疗效果进行了分析。结果本次研究的25例患者中,全部患者的病变直径介于6～13mm,运用内镜黏膜切除术一次性完整切除,病理结果显示:基底及切缘均未见病变残留;患者在实施内镜黏膜切除术后进行1～7个月的随访,内镜复查平均次数为2.12次,在首次内镜复查过程中均发现创面愈合、瘢痕形成,经过碘染色后观察没有发现病变残留和复发。结论内镜黏膜切除术在早期食管癌及癌前病变治疗中的微创优势,是安全、有效的治疗方法 。
Objective To investigate the value of endoscopic mucosal resection in the treatment of early esophageal cancer and precancerous lesions. Methods Twenty-five patients with early esophageal cancer and precancerous lesions admitted to our hospital from January 2011 to April 2012 were enrolled in this study. The therapeutic effects were analyzed. Results Of the 25 patients in this study, the diameter of all the lesions ranged from 6 to 13 mm and were completely removed by endoscopic mucosal resection. The pathological findings showed that no lesions were found in the basal and marginal areas; After mucosal resection for 1 to 7 months follow-up, the average number of endoscopic examination was 2.12 times. During the first endoscopic examination, wound healing and scar formation were found. After iodine staining, no residual lesions and recurrence were observed. Conclusion Endoscopic mucosal resection in early esophageal cancer and precancerous lesions in the treatment of minimally invasive advantages, is a safe and effective treatment.